Dr. Frank is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1364 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-778-6510
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1990 - 1993
Yale-New Haven Medical CenterResidency, Internal Medicine, 1986 - 1989
Yale School of MedicineClass of 1986
Certifications & Licensure
GA State Medical License 2021 - 2026
MA State Medical License 1990 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2002
Publications & Presentations
PubMed
- Dissecting Out a Rare Mutation, STAT: Features of STAT3-Mutant Myeloid Neoplasms.Michael J Hochman, David A Frank
Clinical Cancer Research. 2024-10-15 - 1 citationsOncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation.Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad, Tiara Hamilton, David A Frank
Cancers. 2024-03-31 - 1 citationsInvestigating the anti-cancer potential of pyrimethamine analogues through a modern chemical biology lens.Jennifer I Brown, Rosanne Persaud, Petar Iliev, Ujjwala Karmacharya, Sanaz Attarha
European Journal of Medicinal Chemistry. 2024-01-15
Journal Articles
- Study of Cathepsin B Inhibition in VEGFR TKI Treated Human Renal Cell Carcinoma XenograftsDavid A Frank, Rupal S Bhatt, Seth L Alper, Prateek Khanna, Nature
Press Mentions
Covid-19 AI Update: NIH Developing Imaging ToolsAugust 13th, 2020
Cancer Care Patients and Families Prioritize High-Quality Relationships and CommunicationSeptember 21st, 2017- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and NeckNovember 9th, 2016
Grant Support
- Dual Stat3/Nf-Kb Inhibitors For Targeted Cancer TherapyNational Cancer Institute2012
- STAT3 In The Pathogenesis And Treatment Of Pancreatic CancerNational Cancer Institute2006–2007
- High Throughput Screening For Modulators Of STAT5 (RMI)National Institute Of Neurological Disorders And Stroke2004
- STAT Signaling In Chronic Lymphocytic LeukemiaNational Cancer Institute1999–2003
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
